Clinical & Pharma

Is Policy Ignoring the Long-Term Risks of COVID?
Clinical & Pharma Is Policy Ignoring the Long-Term Risks of COVID?

While the acute phase of the global health crisis has subsided from public consciousness, a far more insidious threat continues to unfold with profound implications for millions worldwide. Years after the initial outbreak, society has largely moved on, adopting a narrative of endemic coexistence

Canadian Trial Tests Novel Cream to Reduce Burn Scars
Clinical & Pharma Canadian Trial Tests Novel Cream to Reduce Burn Scars

For individuals who have survived severe burn injuries, the initial trauma is often just the beginning of a long and arduous journey, with the subsequent scarring presenting a formidable, lifelong challenge. These scars can do more than alter one's appearance; they frequently cause chronic pain and

Why Is AstraZeneca Betting $15 Billion on China?
Clinical & Pharma Why Is AstraZeneca Betting $15 Billion on China?

In a move that reverberates across the global pharmaceutical landscape, AstraZeneca has committed to a monumental $15 billion long-term investment in China, signaling a profound strategic alignment with the nation's rapidly ascending role as a biopharmaceutical powerhouse. This massive financial

How Epidemiology Pinpoints Contaminated Food
Clinical & Pharma How Epidemiology Pinpoints Contaminated Food

When a foodborne illness outbreak quietly begins, it doesn't announce itself with a single, dramatic event but rather as a series of disconnected and unfortunate incidents—a person in one state, a family in another, all suffering from the same severe symptoms. For public health officials, these

Italy's Pharma Sector Fuels Economic Transformation
Clinical & Pharma Italy's Pharma Sector Fuels Economic Transformation

For decades, the "Made in Italy" brand has evoked images of high fashion, luxury automobiles, and gourmet food, but a profound economic shift over the last ten years has added a new, high-tech dimension to this identity. The nation's pharmaceutical sector has quietly undergone a remarkable

HIV Pioneer Myron Cohen to Step Down as IGHID Director
Clinical & Pharma HIV Pioneer Myron Cohen to Step Down as IGHID Director

A monumental shift in leadership is set for this June, as Dr. Myron (Mike) Cohen, a towering figure in infectious disease research and the founding director of the Institute for Global Health and Infectious Diseases (IGHID), has announced he will be stepping down from his role. This transition

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later